APOE and Alzheimer disease: Induced pluripotent stem cells (iPSCs) study found that utilizing CRISPR/Cas9 (a genome‐editing system) to convert APOE4 to APOE3 was sufficient to attenuate multiple AD‐related pathologies [153].